Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis

Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis

Background: Intestinal Fusobacterium nucleatum (F. nucleatum) infection has been implicated into the progression of colorectal cancer (CRC). However, F. nucleatum as a biomarker in 5-fluorouracil (5-FU) resistance of CRC has not been fully analyzed by comparing with other types of gut microbiota. In...

Full description

Bibliographic Details
Main Authors:	Wen-Yu Wang, Hang Zhou, Zhi Wang, Yu-Hang Zhang
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Cancer Treatment and Research Communications
Subjects:	5-Fluorouracil (5-FU) resistance Colorectal cancer (CRC) Fusobacterium nucleatum (F. nucleatum, Fn) Bacteroides fragilis (B. fragilis) Escherichia coli (E. coli)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468294222000272

Similar Items

Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study
by: Aref Shariati, et al.
Published: (2021-06-01)

Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort
by: Dengmei Gong, et al.
Published: (2023-08-01)

Enterotoxigenic and nontoxigenic Bacteroides fragilis strains isolated in Brazil
by: Karla R Miranda, et al.
Published: (2008-11-01)

Detection of Streptococcus gallolyticus and Four Other CRC-Associated Bacteria in Patient Stools Reveals a Potential “Driver” Role for Enterotoxigenic Bacteroides fragilis
by: Bruno Périchon, et al.
Published: (2022-03-01)

Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
by: Sheng Zhang, et al.
Published: (2019-01-01)

Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer
by: Seul A. Lee, et al.
Published: (2019-07-01)

Clinical aspects of experimental peritonitis in horses Aspectos clínicos da peritonite experimental em eqüinos
by: Luiz Cláudio Nogueira Mendes, et al.
Published: (1999-09-01)

A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer
by: Nancy Scott, et al.
Published: (2022-07-01)

Antagonic effect of the inhibition of inducible nitric oxide on the mortality of mice acutely infected with Escherichia coli and Bacteroides fragilis
by: R.S. Astolfi, et al.
Published: (2007-03-01)

Virulence markers and antimicrobial susceptibility of bacteria of the Bacteroides fragilis group isolated from stool of children with diarrhea in São Paulo, Brazil
by: Viviane Nakano, et al.
Published: (2004-05-01)

Extraction and Evaluation of Outer Membrane Vesicles from Two Important Gut Microbiota Members, Bacteroides fragilis and Bacteroides thetaiotaomicron
by: Sara Ahmadi Badi, et al.
Published: (2020-10-01)

Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina Tendencias en el perfil de sensibilidad de aislamientos del grupo Bacteroides fragilis obtenidos en Buenos Aires, Argentina
by: L. Fernández Canigia, et al.
Published: (2007-09-01)

Peritonite experimental em eqüinos. Aspectos hematológicos e bioquímicos
by: Luiz Cláudio Nogueira Mendes, et al.
Published: (2000-01-01)

Cross-Resistance to Other Antimicrobials Among Clindamycin Resistant Bacteroides fragilis and Bacteroides thetaiotaomicron Strains
by: Nurver ÜLGER TOPRAK, et al.
Published: (2005-03-01)

Fusobacterium Nucleatum Empyema: An Atypical Presentation
by: Lucía Barrera López, et al.
Published: (2020-04-01)

Progress in Fusobacterium nucleatum
by: MAO Xuhu, et al.
Published: (2019-10-01)

High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients
by: Nasibeh Khodaverdi, et al.
Published: (2021-12-01)

Targeting Programmed <i>Fusobacterium nucleatum</i> Fap2 for Colorectal Cancer Therapy
by: Kumar Ganesan, et al.
Published: (2019-10-01)

Endophthalmitis caused by Bacteroides fragilis after pars plana vitrectomy and treatment approach
by: Hakan Yildirim, et al.
Published: (2022-01-01)

Osteomyelitis of a long bone due to <it>Fusobacterium nucleatum</it> and <it>Actinomyces meyeri</it> in an immunocompetent adult: A case report and literature review
by: Lee Min, et al.
Published: (2012-07-01)

Fusobacterium nucleatum: from a classic periodontal pathogen to a complete participant of carcinogenesis
by: Kaiumov K.A., et al.
Published: (2023-03-01)

Bacteroides fragilis endocarditis: a case report and review of literature
by: Cristhieni Rodrigues, et al.

The Role of the Bacteroides spp. in Bacteraemia
by: Wysocki Mateusz, et al.
Published: (2022-03-01)

Emergence of Metronidazole-Resistant Bacteroides fragilis, India
by: Rama Chaudhry, et al.
Published: (2001-06-01)

Fusobacterium nucleatum dissemination by neutrophils
by: Felix Ellett, et al.
Published: (2023-12-01)

Fusobacterium nucleatum and Colorectal Cancer
by: Li R, et al.
Published: (2022-03-01)

Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1
by: Chamutal Gur, et al.
Published: (2019-06-01)

Brain abscess and periodontal pathogens (Fusobacterium Nucleatum). Report of a case
by: Debora Franceschi, et al.
Published: (2020-12-01)

Prevalence of pks + bacteria and enterotoxigenic Bacteroides fragilis in patients with colorectal cancer
by: Manon Oliero, et al.
Published: (2022-12-01)

Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis
by: Xiaowen Huang, et al.
Published: (2020-11-01)

Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait
by: Wafaa Jamal, et al.
Published: (2020-01-01)

Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria
by: David eRios-Covian, et al.
Published: (2015-08-01)

Toxigenic and non-toxigenic patterns I, II and III and biofilm-forming ability in Bacteroides fragilis strains isolated from patients diagnosed with colorectal cancer
by: Seyedesomaye Jasemi, et al.
Published: (2020-06-01)

Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta‐analysis
by: Xinyu Zhang, et al.
Published: (2019-02-01)

Isolation and characterization of novel Fusobacterium nucleatum bacteriophages
by: Yue Wang, et al.
Published: (2022-11-01)

Evaluation of the genetic relatedness of Bacteroides fragilis isolates by TRs analysis
by: Niloofar Khodaei, et al.
Published: (2020-10-01)

Fusobacterium nucleatum Subspecies Differ in Biofilm Forming Ability in vitro
by: Maria Muchova, et al.
Published: (2022-03-01)

Diagnostic Performance of Intestinal Fusobacterium nucleatum in Colorectal Cancer: A Meta-Analysis
by: Bo-Jian Peng, et al.
Published: (2018-01-01)

Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System
by: Jawad Abed, et al.
Published: (2020-08-01)

Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study
by: H. Cuellar-Gómez, et al.
Published: (2022-07-01)